The interplay between DNA and histone methylation: molecular mechanisms and disease implications

Y Li, X Chen, C Lu - EMBO reports, 2021 - embopress.org
Methylation of cytosine in CpG dinucleotides and histone lysine and arginine residues is a
chromatin modification that critically contributes to the regulation of genome integrity …

Mechanisms that regulate the activities of TET proteins

K Joshi, S Liu, P Breslin SJ, J Zhang - Cellular and Molecular Life Sciences, 2022 - Springer
The ten–eleven translocation (TET) family of dioxygenases consists of three members,
TET1, TET2, and TET3. All three TET enzymes have Fe+ 2 and α-ketoglutarate (α-KG) …

Genomic profiling for clinical decision making in lymphoid neoplasms

L De Leval, AA Alizadeh, PL Bergsagel… - Blood, The Journal …, 2022 - ashpublications.org
With the introduction of large-scale molecular profiling methods and high-throughput
sequencing technologies, the genomic features of most lymphoid neoplasms have been …

Age-related clonal hematopoiesis associated with adverse outcomes

S Jaiswal, P Fontanillas, J Flannick… - … England Journal of …, 2014 - Mass Medical Soc
Background The incidence of hematologic cancers increases with age. These cancers are
associated with recurrent somatic mutations in specific genes. We hypothesized that such …

TET2 mutations are associated with hypermethylation at key regulatory enhancers in normal and malignant hematopoiesis

M Tulstrup, M Soerensen, JW Hansen… - Nature …, 2021 - nature.com
Mutations in the epigenetic modifier TET2 are frequent in myeloid malignancies and clonal
hematopoiesis of indeterminate potential (CHIP) and clonal cytopenia of undetermined …

Regulatory mechanisms of epigenetic miRNA relationships in human cancer and potential as therapeutic targets

KMT Arif, EK Elliott, LM Haupt, LR Griffiths - Cancers, 2020 - mdpi.com
Simple Summary By the virtue of targeting multiple genes, a microRNA (miRNA) can infer
variable consequences on tumorigenesis by appearing as both a tumour suppressor and …

Loss of TET2 in hematopoietic cells leads to DNA hypermethylation of active enhancers and induction of leukemogenesis

KD Rasmussen, G Jia, JV Johansen… - Genes & …, 2015 - genesdev.cshlp.org
DNA methylation is tightly regulated throughout mammalian development, and altered DNA
methylation patterns are a general hallmark of cancer. The methylcytosine dioxygenase …

The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases

E Solary, OA Bernard, A Tefferi, F Fuks, W Vainchenker - Leukemia, 2014 - nature.com
Abstract Ten-Eleven Translocation-2 (TET2) inactivation through loss-of-function mutation,
deletion and IDH1/2 (Isocitrate Dehydrogenase 1 and 2) gene mutation is a common event …

TET proteins and the control of cytosine demethylation in cancer

L Scourzic, E Mouly, OA Bernard - Genome medicine, 2015 - Springer
The discovery that ten-eleven translocation (TET) proteins are α-ketoglutarate-dependent
dioxygenases involved in the conversion of 5-methylcytosines (5-mC) to 5 …

TET2 deficiency causes germinal center hyperplasia, impairs plasma cell differentiation, and promotes B-cell lymphomagenesis

PM Dominguez, H Ghamlouch, W Rosikiewicz… - Cancer discovery, 2018 - AACR
TET2 somatic mutations occur in∼ 10% of diffuse large B-cell lymphomas (DLBCL) but are
of unknown significance. Herein, we show that TET2 is required for the humoral immune …